Mucosal response of inactivated and recombinant COVID-19 vaccines in Congolese individuals
Description
CONCLUSION: Inactivated and recombinant COVID-19 vaccines in use in the Republic of Congo poorly activated mucosal IgA-mediated antibody response 2 months postvaccination.
